Research programme: guanylate cyclase stimulants - Abbvie
Alternative Names: guanylate cyclase stimulants research programme - Abbott LaboratoriesLatest Information Update: 24 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class
- Mechanism of Action Guanylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 18 Sep 2006 Discontinued - Preclinical for Erectile dysfunction in USA (unspecified route)
- 20 Sep 2002 Preclinical trials in Erectile dysfunction in USA (unspecified route)